Individual provider · Type 1 NPI
Charles Vernon Capen, MD
Gynecologic Oncology Physician · Temple, TX
NPI number
1477512119
Active
Practice location
2401 S 31st St
Temple, TX 76508-0001
Mailing address
PO Box 844658
Dallas, TX 75284-4658
Specialties and licenses
| Taxonomy | Code | License |
|---|---|---|
| Gynecologic Oncology Physician Primary | 207VX0201X | G4093 (TX) |
| Obstetrics & Gynecology Physician | 207V00000X | G4093 (TX) |
Gynecologic Oncology Physician: An obstetrician/gynecologist who provides consultation and comprehensive management of patients with gynecologic cancer, including those diagnostic and therapeutic procedures necessary for the total care of the patient with gynecologic cancer and resulting complications.
1,989 other providers at this address
- Scott & White ClinicInternal Medicine Physician Temple, TX NPI 1093779704
- Scott & White ClinicPediatrics Physician Temple, TX NPI 1194849281
- Scott & White ClinicPediatrics Physician Temple, TX NPI 1386933182
- Scott & White ClinicAudiologist-Hearing Aid Fitter Temple, TX NPI 1477924553
- Scott & White ClinicPediatrics Physician Temple, TX NPI 1568586659
- Scott & White ClinicCertified Registered Nurse Anesthetist Temple, TX NPI 1871626143
- Scott & White ClinicDental Clinic/Center Temple, TX NPI 1962468355
- Scott & White Ems, IncAmbulance Temple, TX NPI 1144414228
- Scott & White HealthcareGeneral Acute Care Hospital Temple, TX NPI 1093053555
- Scott & White HospitalGeneral Acute Care Hospital Temple, TX NPI 1609213552
- Scott & White Memorial HospitalDurable Medical Equipment & Medical Supplies Temple, TX NPI 1083543110
- Scott & White Memorial HospitalAmbulatory Surgical Clinic/Center Temple, TX NPI 1457470262
Other gynecologic oncology physician providers in Temple
About NPI 1477512119
Charles Vernon Capen, MD's National Provider Identifier is 1477512119, issued on Mar 21, 2006. The primary taxonomy on file is Gynecologic Oncology Physician (207VX0201X), and the practice location is in Temple, TX. The record was last updated on Oct 20, 2021.